CVX-210-H

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCVX-210-H
Drug Alias Nameatherosclerosis vaccine (CardioVax/Lund University Hospital/Cedars-Sinai Heart Institute)P-210CVX-210-H
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionSerum albumin modulatorsApolipoprotein B-100 modulators
TargetsApolipoprotein B-100Serum albumin
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbcentra LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbcentra LLCSkane University HospitalCedars-Sinai Medical Center
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A